| |
| |
|
|
A BILL TO BE ENTITLED
|
|
|
AN ACT
|
|
|
relating to a study on the use of alternative therapies for treating |
|
|
post-traumatic stress disorder. |
|
|
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: |
|
|
SECTION 1. Sections 1(b), (c), (d), and (f), Chapter 983 |
|
|
(H.B. 1802), Acts of the 87th Legislature, Regular Session, 2021, |
|
|
are amended to read as follows: |
|
|
(b) The commission, in collaboration with Baylor College of |
|
|
Medicine and in partnership with a military veterans hospital, [or] |
|
|
a medical center that provides medical care to veterans, or a |
|
|
facility licensed in this state that provides Ketamine-related |
|
|
mental health services, shall conduct a study on the efficacy of |
|
|
using alternative therapies, including the use of |
|
|
3,4-methylenedioxymethamphetamine (MDMA), psilocybin, and |
|
|
ketamine, in the treatment of veterans and other identified |
|
|
individuals who suffer from post-traumatic stress disorder. |
|
|
(c) In conducting the study described by Subsection (b) of |
|
|
this section, the commission in collaboration with the Baylor |
|
|
College of Medicine shall: |
|
|
(1) perform a clinical trial on the therapeutic |
|
|
efficacy of using psilocybin in the treatment of |
|
|
treatment-resistant post-traumatic stress disorder in veterans and |
|
|
other identified individuals; [and] |
|
|
(2) prescribe standardized protocols for each |
|
|
researcher or research organization participating in the study; and |
|
|
(3) review current literature regarding: |
|
|
(A) the safety and efficacy of |
|
|
3,4-methylenedioxymethamphetamine (MDMA), psilocybin, and |
|
|
ketamine in the treatment of post-traumatic stress disorder; and |
|
|
(B) the access veterans and other identified |
|
|
individuals have to 3,4-methylenedioxymethamphetamine (MDMA), |
|
|
psilocybin, and ketamine for treatment of post-traumatic stress |
|
|
disorder in the United States. |
|
|
(d) The commission shall prepare and submit to the governor, |
|
|
the lieutenant governor, the speaker of the house of |
|
|
representatives, and each member of the legislature: |
|
|
(1) quarterly reports on the progress of the study |
|
|
conducted under this section; and |
|
|
(2) not later than December 1, 2026 [2024], a written |
|
|
report containing the results of the study conducted under this |
|
|
section and any recommendations for legislative or other action. |
|
|
(f) This Act expires September 1, 2027 [2025]. |
|
|
SECTION 2. This Act takes effect immediately if it receives |
|
|
a vote of two-thirds of all the members elected to each house, as |
|
|
provided by Section 39, Article III, Texas Constitution. If this |
|
|
Act does not receive the vote necessary for immediate effect, this |
|
|
Act takes effect September 1, 2023. |